- Trials with a EudraCT protocol (32)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
32 result(s) found for: Renal sinus.
Displaying page 1 of 2.
EudraCT Number: 2021-005273-47 | Sponsor Protocol Number: I8F-MC-GPIG | Start Date*: 2022-11-21 | ||||||||||||||||
Sponsor Name:Eli Lilly and Company | ||||||||||||||||||
Full Title: Tirzepatide Study of Renal Function in People with Overweight or Obesity and Chronic Kidney Disease with or without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease usin... | ||||||||||||||||||
Medical condition: Obesity and Chronic Kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Trial now transitioned) DK (Trial now transitioned) AT (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002673-38 | Sponsor Protocol Number: CRLX030A2211 | Start Date*: 2015-11-24 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, randomized, double-blind, crossover placebo-controlled Phase II study to assess the effect of serelaxin versus placebo on high sensitivity cardiac troponin I (hs-cTnI) release in pat... | |||||||||||||
Medical condition: Chronic Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003662-14 | Sponsor Protocol Number: GN17CA082 | Start Date*: 2019-05-13 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: Patiromer-facilitated, dose-escalation of mineralocorticoid antagonists for the management of worsening congestion in people with heart failure and hyperkalaemia. A Phase IV, registry-based, rand... | |||||||||||||
Medical condition: People with heart failure, worsening symptoms and signs of congestion and serum potassium >5mmol/L | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002168-17 | Sponsor Protocol Number: BAY94-8862/16275 | Start Date*: 2015-12-09 | |||||||||||||||||||||||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||||||||||||||||||||||
Full Title: A multicenter, randomized, double-blind, double-dummy, parallel-group, active-controlled study to evaluate the efficacy and safety of finerenone compared to eplerenone on morbidity and mortality in... | |||||||||||||||||||||||||||||||||
Medical condition: Subjects with chronic heart failure and reduced ejection fraction after recent heart failure decompensation and additional risk factors, either type 2 diabetes mellitus or chronic kidney disease or... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: SE (Prematurely Ended) DK (Prematurely Ended) IE (Prematurely Ended) CZ (Prematurely Ended) DE (Prematurely Ended) FI (Prematurely Ended) GB (Prematurely Ended) AT (Prematurely Ended) HU (Prematurely Ended) NL (Prematurely Ended) PT (Prematurely Ended) ES (Prematurely Ended) LT (Prematurely Ended) BG (Prematurely Ended) PL (Prematurely Ended) GR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004202-25 | Sponsor Protocol Number: PI18/01297 | Start Date*: 2019-06-05 | |||||||||||
Sponsor Name:Luis Nombela Franco | |||||||||||||
Full Title: Usefulness of amiodarone for the Prevention of new onset Atrial Fibrillation after transcatheter aortic valve implantation: a randomized controlled trial | |||||||||||||
Medical condition: atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011637-27 | Sponsor Protocol Number: CHARTT-001 | Start Date*: 2010-08-24 |
Sponsor Name:Hull and East Yorkshire NHS Hospital Trust | ||
Full Title: Clopidogrel versus Aspirin in Chronic Heart Failure | ||
Medical condition: Heart Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-002829-21 | Sponsor Protocol Number: SUS2011DIKE01 | Start Date*: 2013-03-18 | |||||||||||
Sponsor Name:Stavanger Helseforskning AS | |||||||||||||
Full Title: Sildenafil in Chronic Heart Failure; An investigator initiated multi-national clinical research study. | |||||||||||||
Medical condition: Chronic Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005484-31 | Sponsor Protocol Number: 20-197 | Start Date*: 2022-10-07 | |||||||||||
Sponsor Name:CHU CAEN Normandie | |||||||||||||
Full Title: SPironolactONe for the maintenance of Sinus Rhythm in hypertensive patients with atrial fibrillation and preserved left ventricular ejection fraction: a Prospective Randomized Open Blinded End-poin... | |||||||||||||
Medical condition: Hypertensive patients > 18 years referred for documented AF episodes (symptomatic or not) with preserved left ventricular ejection fraction (LVEF). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002019-16 | Sponsor Protocol Number: U-2015-030 | Start Date*: 2016-09-06 | |||||||||||
Sponsor Name:Uppsala Clinical Research center | |||||||||||||
Full Title: Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction | |||||||||||||
Medical condition: Heart Failure with Preserved Ejection Fraction, HFPEF | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003641-95 | Sponsor Protocol Number: SELECTI-CARFAP | Start Date*: 2015-02-13 | |||||||||||
Sponsor Name:Nicasio PĂ©rez Castellano | |||||||||||||
Full Title: Randomized clinical trial to study effective pharmacological cardioversion of paroxysmal atrial fibrillation by blocking ionic currents atrioselectivas by treatment with vernakalant vs Flecainide | |||||||||||||
Medical condition: Atrial fibrillation paroxysmal | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003126-23 | Sponsor Protocol Number: D6402C00001 | Start Date*: 2021-02-23 | ||||||||||||||||
Sponsor Name:AstraZeneca AB | ||||||||||||||||||
Full Title: A Phase 2b, Randomised, Double-Blind, Active-Controlled, Multi-Centre Study to Evaluate the Efficacy, Safety and Tolerability of Oral AZD9977 and Dapagliflozin Treatment in Patients with Heart Fail... | ||||||||||||||||||
Medical condition: Heart Failure and Chronic Kidney Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) LT (Completed) HU (Completed) DK (Completed) SE (Completed) CZ (Completed) SK (Completed) BG (Completed) PL (Completed) DE (Completed) IT (Completed) ES (Restarted) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-004271-14 | Sponsor Protocol Number: DAPAS | Start Date*: 2021-12-06 | |||||||||||
Sponsor Name:Aarhus University Hospital, department of Cardiology | |||||||||||||
Full Title: Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention | |||||||||||||
Medical condition: Patients with aortic stenosis undergoing trans catheter aortic valve replacement. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005724-10 | Sponsor Protocol Number: SPIHF-201 | Start Date*: 2016-06-07 | |||||||||||
Sponsor Name:Stealth BioTherapeutics Inc. | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of Multiple Subcutaneous Injections of Elamipretide on Left Ventricular Function in Subjects with Stable Heart... | |||||||||||||
Medical condition: Stable Heart Failure with Reduced Ejection Fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004133-16 | Sponsor Protocol Number: IH141 | Start Date*: 2015-02-19 |
Sponsor Name:Hull and east Yorkshire Hospitals Trust | ||
Full Title: Exploratory multicentre prospective double blinded randomised controlled pilot study of the effect of intravenous iron supplementation(Monofer)in iron deficient but not anaemic patients with Chroni... | ||
Medical condition: Chronic Kidney Disease stages 3b to 5 with iron deficiency | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000306-29 | Sponsor Protocol Number: 20103 | Start Date*: 2021-10-04 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NY... | |||||||||||||
Medical condition: Heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) DK (Completed) AT (Completed) HU (Completed) BG (Completed) PT (Completed) NL (Completed) SK (Completed) GR (Completed) CZ (Completed) LT (Completed) FI (Completed) LV (Completed) IT (Completed) RO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000075-33 | Sponsor Protocol Number: SINTART1 | Start Date*: 2013-05-04 | |||||||||||
Sponsor Name:Fondazione IRCCS Istituto Nazionale Tumori | |||||||||||||
Full Title: Multidisciplinary approach for poor prognosis sinonasal tumors: Phase II study of chemotherapy, surgery, photon and heavy ion radiotherapy integration for more effective and less toxic treatment in... | |||||||||||||
Medical condition: Poor prognosis sinonasal tumors in operable patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001922-24 | Sponsor Protocol Number: 120541 | Start Date*: 2013-07-12 | |||||||||||
Sponsor Name:University College London (UCL) | |||||||||||||
Full Title: The effect of remote ischaemic preconditioning and glyceryl trinitrate on peri-operative myocardial injury in cardiac bypass surgery patients (ERIC-GTN study)- a four arm randomised controlled trial | |||||||||||||
Medical condition: We are investigating the phenomenon of ischaemic-reperfusion injury. Reperfusion of the ischaemic myocardium is known to cause further myocardial damage. We wish to investigate the phenomenon of Re... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000038-12 | Sponsor Protocol Number: 10/0216 | Start Date*: 2011-09-13 | |||||||||||
Sponsor Name:University College London (UCL) | |||||||||||||
Full Title: A Phase 2b randomised, double blind, placebo-controlled trial of trimetazidine therapy in patients with non-obstructive hypertrophic cardiomyopathy. | |||||||||||||
Medical condition: Hypertrophic cardiomyopathy (non-obstructive) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003349-14 | Sponsor Protocol Number: AIO-KHT-0117 | Start Date*: 2018-05-03 | ||||||||||||||||
Sponsor Name:AIO-Studien-gGmbH | ||||||||||||||||||
Full Title: A randomized phase II study on the optimization of immunotherapy in squamous carcinoma of the head and neck (OPTIM) | ||||||||||||||||||
Medical condition: recurrent or metastatic squamous cell carcinoma of the head and neck (R/M-SCCHN) progressing after prior platinum-based therapy (radiochemo-therapy or systemic chemotherapy) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001179-19 | Sponsor Protocol Number: UC-0160/1210 | Start Date*: 2014-10-14 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: Prospective phase II study of Gemcitabine plus platinium salt in combination with bevacizumab (Avastin®) for metastatic collecting duct carcinoma. | |||||||||||||
Medical condition: Metastatic collecting duct carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
